Research library
GLP-1 articles and research updates
Follow the source behind an approval, medication instruction or price. Research dates and evidence limits are visible in every updated article.
Choosing care
Comparing smaller GLP-1 providers: six checks before enrolling
Look beyond the familiar platform names. Compare the clinical practice, pharmacy, exact product, invoice and refill process behind a smaller provider’s offer.
Costs and access
Prepaid GLP-1 plans: what to check before a three-month commitment
A lower monthly equivalent can come with a larger first payment, multiple vials and a narrow cancellation window. Compare the commitment as well as the price.
Pharmacy and safety
How to check an online GLP-1 pharmacy before ordering
Identify the dispensing pharmacy, verify its state license and recognize warning signs. A provider’s pharmacy-network claim is only a starting point.
Medication routine
Traveling with GLP-1 medication: storage, supplies and refills
Prepare around the exact product and device. Refrigeration rules, room-temperature limits and a missed dose require separate answers.
Medication safety
GLP-1 vial labels: why milligrams, milliliters and units are different
A vial concentration, prescribed amount and syringe marking describe different things. Resolve the instructions with the pharmacist rather than borrowing another patient’s conversion.
Nutrition and daily life
Protein and strength training during GLP-1 treatment
Reduced appetite still needs a nutrition plan. Discuss food intake, strength and function rather than treating a protein supplement as complete muscle protection.
Treatment follow-up
When GLP-1 weight loss slows: prepare for a clinical review
A short stretch of unchanged weight is not a diagnosis or a reason to improvise dosing. Put the trend, treatment stage and health goals into context.
Research and maintenance
Stopping a GLP-1: what withdrawal trials show about weight regain
STEP 1 and SURMOUNT-4 show why continuation and stopping deserve a plan. Trial averages do not predict an individual outcome or establish a tapering method.
Procedures and care planning
GLP-1 medication before surgery or endoscopy: tell the care team early
Most patients can continue treatment under current multisociety guidance, but risk factors and procedure plans matter. Obtain instructions from the prescriber and anesthesia team.
Insurance and costs
A GLP-1 insurance denial: organize the reason, records and appeal
Read the written denial before comparing cash prices. Coverage exclusions, missing paperwork and medical-necessity decisions can require different next steps.
Care continuity
Changing GLP-1 providers: records, refills and the next clinical review
A transfer is more than canceling one subscription and opening another. Prepare the prescription history, product details, care handoff and remaining charges.
Medication update
Foundayo: the new oral GLP-1 option and what to check
Orforglipron is now sold as FDA-approved Foundayo for eligible adults. Understand how its instructions, interactions and access differ from oral Wegovy.
Regulation and safety
Compounded GLP-1s after the shortage: what the current FDA guidance says
Shortage-era access is not a permanent approval. Learn the current evidence and regulatory limits, plus the practical questions to ask about a prescription.
Costs and access
How to compare GLP-1 costs without missing the renewal bill
Separate the care fee, medicine, starting promotion and prepaid commitment. A practical comparison using current provider and manufacturer terms.
Starting treatment
Considering GLP-1 treatment: questions for the first visit
Prepare for a clinical decision about eligibility, medication choice, risks, costs and long-term care.
Starting treatment
The first month of semaglutide: routine, tolerability and follow-up
The first month establishes a safe administration routine and response review. It does not predict a guaranteed weight-loss result.
Safety
GLP-1 side effects: a plan for follow-up and warning symptoms
Understand common symptoms, when to seek prompt care and why dose or medicine changes require your clinical team.
Treatment follow-up
A six-month GLP-1 review: response, tolerability and the next plan
Review progress with your clinician using more than a scale number, without treating an invented milestone as a standard.
Food and wellbeing
Food concerns during GLP-1 treatment: avoid self-diagnosis
A medication article cannot diagnose eating behavior. Bring appetite changes, distress and difficulty eating to a qualified clinical team.
Food and wellbeing
Changes in appetite and food routines: keeping care and wellbeing connected
Discuss food intake, distress and mood changes without turning a fictional narrative into evidence about a medicine.
Insurance and costs
GLP-1 insurance and access in 2026: coverage is product- and pathway-specific
Check your prescription, benefit rules and the Medicare GLP-1 Bridge rather than assume an older blanket coverage rule still applies.
Medication comparison
Ozempic, Wegovy, Mounjaro and current weight-management choices
Shared ingredients do not make brand indications, formulations or dosing interchangeable. The current comparison also includes Zepbound and Foundayo.
Daily life
Talking about GLP-1 treatment: privacy, support and informed decisions
Your treatment decisions belong in a qualified care conversation. Practical ways to keep disclosure and support on your terms.
Progress and expectations
What a 100-pound weight-loss headline cannot tell you
A large weight-loss claim does not establish a typical result, a treatment choice or the plan needed to maintain health.
Long-term care
Maintaining weight loss: continuation, follow-up and treatment changes
Review long-term care with your clinician instead of assuming a target weight means medication can be stopped without a plan.
Medication update
Wegovy tablets are approved: the original announcement, updated
The oral Wegovy option is now part of current care. Its approved formulation, instructions and current access terms matter more than an old launch forecast.
Medication profile
Wegovy tablet review: instructions, evidence, costs and limits
A document-based review of approved oral Wegovy, without invented personal experience or unsupported star ratings.